Microdosing For Mind and Body

“Every guest in this room is taking Mounjaro,” Paris-based clothes designer R.L. overheard at an early 2025 dinner party of about two dozen people in South Florida. While some aimed to lose weight, others were microdosing the drug with the primary goal of clearing brain fog and staving off any deterioration of brain function. To date, about 13% of Americans have taken “GLP-1” drugs like Mounjaro and Ozempic—some for weight-loss but most to treat type 2 diabetes and medical conditions associated with obesity.

Different GLP-1 drugs raise insulin production to lower blood sugar levels or slow the stomach’s emptying to create feelings of fullness. People who microdose, taking one-third to one-tenth of the typical prescription amount, are seeking related health effects, notably protection of both the heart and the brain. Besides clearing brain fog, reducing blood sugar may offer long-term protection against dementia—with Alzheimer’s disease being dubbed a third type of diabetes—despite an absence of research on the effects from microdosing GLP-1 drugs.

Microdosing to boost brain function has become familiar in recent years among biohackers working in tech fields. Last year, according to The Wall Street Journal, microdosing ketamine, LSD, and shrooms to improve focus and productivity was so popular in Silicon Valley that it had become “a routine part of doing business” for many—despite research casting doubt on the biohackers’ claims.

“It’s just a data-free zone,” Cornell University obesity specialist Sarah Barenbaum said about microdosing GLP-1 drugs in a healthline.com report. “I would say [any health benefit to body and brain is] not impossible, it just hasn’t been studied.” Other reasons people give for microdosing GLP-1 drugs are keeping off the pounds they had already lost on full doses of the drug and reducing side effects, which are mostly gastrointestinal.

But the drugs’ high price tag—around $1,000/month for a full dose—is the most common reason people try microdosing. Cost is also the reason more than 50% of people prescribed the drugs stop taking them. Most people seeking GLP-1 drugs for weight loss usually can’t get insurance to cover the expense. And without a medical diagnosis like type 2 diabetes or heart disease, many have trouble finding a physician willing to prescribe the drugs.

Everyone who loses weight on GLP-1 drugs faces the near-impossibility of keeping off extra pounds without continuing to take a full dose. “It was overwhelming. I had a voracious appetite that could not be satisfied,” said South Florida food services executive C.M., who lost almost 60 pounds on Zepbound.

Share

Despite limiting her food intake, C.M. gained back about five pounds a week after stopping the drug. Ultimately, C.M.’s doctor helped with a slow tapering of the dose—by starting her back at the full 10 mg/week and then adding alternate weeks of 7.5 mg to “avoid shocking the body.” Even on smaller doses, C.M. and others taking GLP-1 drugs describe a cliff effect, like that of Antabuse for alcohol: After a certain point in a meal, a strong feeling of fullness tells them that just one more bite risks causing terrible nausea—a side effect some try to avoid by microdosing.

The biggest potential health concern with microdosing is that patients might take an inadequate amount to treat serious conditions for which the drug was originally prescribed. To help patients with the expense, Barenbaum and others say they sometimes demonstrate how to manually toggle the commercial injection pens, which are pre-filled with the drugs, to reduce dosages—although she cautions that patients taking lower doses are not “very successful long term.”

Compounding pharmacies offer a less expensive source for both full- and micro-doses of GLP-1 drugs—but patients must measure and administer the medication themselves, with risks that include infection and overdose. According to healthline.com., “Overdoses and calls to poison control centers have spiked in the United States with the growth and availability of compounded GLP-1s.”

GLP-1 drugs at full dose, on the other hand, have plenty of research to support beneficial effects throughout the body, because high levels of circulating glucose can damage nerves and blood vessels and create risks for everyone that are similar to those of diabetes. The greatest risk is cardiovascular disease—which can lead to heart attack and stroke—while others include kidney damage and diminished eyesight. To counter these, insulin processes glucose—removing it from circulation and decreasing damange to blood vessels.

“GLP-1 can play an important role in different metabolic disorders [and] lead to improvements in brain glucose metabolism and glucose transport across the blood–brain barrier in Alzheimer’s disease,” according to a multi-center biochemical research team in Brazil. In addition, these drugs “can alleviate depressive symptoms and be used to improve quality of life and depression scales.”

For microdosers who tout reduced brain fog, however, improvement in brain function is notoriously difficult to assess—as is true with many difficult-to-measure symptoms, such as pain and sleep difficulties. Anecdotal reports and the placebo effect can also influence personal observations. As with vitamins and other supplements, as well as with CBD formulations containing no psychoactive THC, most have no solid scientific support. But people’s belief that they’re improving their health can make them feel better.

Being over the age of 45 is now considered a risk factor for diabetes—along with excess weight, high blood pressure, and family history. On the other hand, while elevated blood levels of glucose are the real villain, many people blame sugar intake alone.

I like sugar and sugary foods—and when friends hound me about adding a cube of sugar to my tea, I consider reducing my daily amount. Most recently, I contemplated a sugar-free January—but when life became hectic, I postponed that plan for another year.